Literature DB >> 16741041

Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.

Kamakshi Sachidanandam1, Alex Harris, Jimmie Hutchinson, Adviye Ergul.   

Abstract

Vascular dysfunction characterized by a hyperreactivity to vasoconstrictors and/or impaired vascular relaxation contributes to increased incidence of cardiovascular disease in diabetes. Endothelin (ET)-1, a potent vasoconstrictor, is chronically elevated in diabetes. However, the role of ET-1 in resistance versus larger vessel function in mild diabetes remains unknown. Accordingly, this study investigated vascular function of third-order mesenteric arteries and basilar arteries in control Wistar and Goto-Kakizaki (GK) rats, a model of mild Type 2 diabetes. Six weeks after the onset of diabetes, contractile responses to 0.1-100 nM ET-1 and relaxation responses to 1 nM-10 microM acetylcholine (ACh) in vessels preconstricted (baseline + 60%) with serotonin (5-HT) were assessed by myograph studies in the presence or absence of a nitric oxide synthase (NOS) inhibitor, N-nitro-L-arginine (L-NNA). Maximum contractile response to ET-1 was augmented in mesenteric vessels (155 +/- 18% in GK vs. 81 +/- 6% in control; n = 5-7) but not in the basilar artery (134 +/- 29% in GK vs. 107 +/- 17% in control; n = 4 per group). However, vascular relaxation was impaired in the basilar arteries (22 +/- 4% in GK vs. 53 +/- 7% in control; n = 4 per group) but not in mesenteric arteries of GK rats. Inhibition of NOS decreased the relaxation response of basilar arteries to 15 +/- 8% and 42 +/- 5% in GK and control rats, respectively; whereas, in resistance vessels, corresponding values were 56 +/- 7% and 89 +/- 3% (vs. 109 +/- 2% and 112 +/- 3% without NOS blockade), indicating the involvement of different vasorelaxation-promoting pathways in these vascular beds. These findings provide evidence that the ET system is activated even under mild hyperglycemia and that it contributes to the hyperreactivity of resistance vessels, therefore, the ET system may play an important role in elevated blood pressure in Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741041

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  12 in total

1.  miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells.

Authors:  Yuk Cheung Chan; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

2.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

3.  Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction.

Authors:  Kyan J Allahdadi; Johanna L Hannan; Adviye Ergul; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2011-06-30       Impact factor: 3.802

4.  Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.

Authors:  Trevor Hardigan; Yasir Abdul; Adviye Ergul
Journal:  Life Sci       Date:  2016-02-17       Impact factor: 5.037

5.  Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177.

Authors:  Fernando S Carneiro; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-08-30       Impact factor: 3.802

6.  Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.

Authors:  Styliani Goulopoulou; Johanna L Hannan; Takayuki Matsumoto; Safia Ogbi; Adviye Ergul; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-08       Impact factor: 4.733

7.  Diabetes-mediated middle cerebral artery remodeling is restored by linagliptin: Interaction with the vascular smooth muscle cell endothelin system.

Authors:  Abdul Yasir; Trevor Hardigan; Adviye Ergul
Journal:  Life Sci       Date:  2016-03-02       Impact factor: 5.037

8.  Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Jim R Hutchinson; Mostafa M Elgebaly; Erin M Mezzetti; Mong-Heng Wang; Adviye Ergul
Journal:  J Pharmacol Exp Ther       Date:  2008-10-21       Impact factor: 4.030

9.  Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.

Authors:  Mostafa M Elgebaly; Aisha Kelly; Alex K Harris; Hazem Elewa; Vera Portik-Dobos; Pimonrat Ketsawatsomkron; Mario Marrero; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2008-06       Impact factor: 2.273

10.  Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.

Authors:  Kyan J Allahdadi; Tom W Cherng; Hemanth Pai; Ana Q Silva; Benjimen R Walker; Leif D Nelin; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-30       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.